Ashley Gallagher, MA

Pharmacists detail a simple, tech-driven revenue cycle management workflow that empowers pharmacies to bill, reconcile, and get paid for clinical services.

New data show illness perception and functional capacity influence each other in older adults with COPD and diabetes after hospital discharge.

Data show that TyG-WC, an index combining insulin resistance and central adiposity, is the only surrogate marker independently linked to osteoporosis.

Policy shifts in Medicare and advancements in automation are creating a massive opportunity for both revenue growth and clinical impact.

A year of ACIP turnover, schedule changes, and lawsuits has fractured US vaccine guidance—and tied pharmacists' scope and billing to a moving target.

The current crisis of staffing shortage is not just a labor shortage but a structural failure in how pharmacies recruit and value their technician workforce.

The expanded approval adds a self-administered autoinjector option and new label language tying LDL-C lowering to reduced cardiovascular risk.

Although DSCSA is often viewed as a regulatory burden, pharmacy leaders illustrate its necessity through harrowing case studies of supply chain failures.

Pharmacy leaders urge regional alliances, scalable clinical services, and data exchange to make pharmacist care reimbursable and routine.

Rural pharmacist explains how local pharmacies close care gaps in older, rural patients by improving vaccine access, education, and on-time immunizations.

Pharmacists must navigate peptide and GLP-1 compounding legally by understanding 503A vs 503B rules.

The academy's updated influenza guidance arrives days after a White House executive order narrowed the recommended childhood vaccine schedule.

Dispensary of Hope delivers donated medications to uninsured patients, cutting emergency room visits and redefining pharmacy’s role in access.

Pharmacies are expanding vaccine access for flu, COVID, and other shots while debunking safety myths and adding test-to-treat services to improve patient care.

Pharmacist-backed travel kit picks tackle motion sickness, dehydration, and stomach upsets for on-the-go relief.

The White House and the American Academy of Pediatrics leave pharmacists navigating 2 competing sets of vaccine guidance for the upcoming season.

A decades-long research effort in mRNA-produced licensed vaccines targets influenza, respiratory syncytial virus, cytomegalovirus, HIV, and cancer.

Data show possible but insignificant reduction in hypertensive disorders of pregnancy after periconceptional or first-trimester GLP-1 exposure.

Community pharmacists deliver travel vaccine clinics, navigate entry rules, and update routine shots with new guidance on polio, measles, and chikungunya.

Data on excess deaths in high-income countries show the male mortality disadvantage during COVID-19 is concentrated in the pandemic's earliest phase.

Counseling, team-based care, and tailored pharmacy interventions remain among the most effective tools against medication nonadherence in the United States.

The approval gives pharmacists a new, nonegg-based seasonal influenza option for adults 50 and older ahead of the 2026-2027 flu season.

Oveporexton, an oral orexin receptor 2 agonist, is the first medicine to restore orexin signaling rather than manage symptoms of the rare sleep disorder.

This medication is the first FDA-approved OTC innovation in the cold and flu category in 14 years.

A study finds treated diabetes prevalence climbs steadily for 5 years after antipsychotic start, even with brief exposure.

Results from a trial show injectable cabotegravir plus rilpivirine reduced viral rebound compared with daily oral therapy.

Community and independent pharmacists are beginning to test whether they can help fill the resulting gaps in medication management for older adults.

Centuries of vaccine science saved more lives than any other intervention, and pharmacists matter now more than ever.

The rapid-acting insulin aspart biosimilar adds a third interchangeable option to NovoLog, with implications for pharmacy dispensing and counseling.

A target trial emulation found early remdesivir initiation was associated with reduced 1-year risk of graft loss and cardiovascular events.